bioRxivImmunologyPreprint
Sialophorin is an essential host element for vaccine immunity against pulmonary fungal infections
Abstract
The global burden of fungal infections is alarming, primarily due to the increasing immune-compromised population. The immuno-preventive/therapeutic measures, including vaccines, are necessary to prevent or control fungal diseases. Identifying a protective host element as a functional phenotypic marker is immensely valuable. We identified a host element, sialophorin, preferentially associated with antifungal memory T cells. We investigated its role in vaccine immunity using a mouse model of pulmonary fungal infection. We found that sialophorin was essential to bolster CD8+ T-cell responses to the vaccine by enhancing their differentiation and expanding cytokine-producing cells required for immunity. Using a gain-of-function approach, activating sialophorin using mAb augmented the CD8+ T cell responses, and sialophorin-sufficient CD8+ T cells were competitively superior in differentiation and expansion to the deficient cells. Sialophorin-mediated vaccine immunity was independent of the T cell trafficking effect. Finally, we show that sialophorin is a potential functional phenotypic marker of fungal vaccine-potency and immunity. Our study revealed that sialophorin is an essential host-target element to bolster vaccine responses and serves as a potential biomarker of fungal immunity. Author SummaryFungal infections have been rising in recent years due to increased immunocompromised individuals. Vaccination of at-risk individuals helps counter the infections. Thus, suitable vaccine platforms are needed with apt adjuvants, and a phenotypic marker of vaccine immunity will bolster the efforts. We identified a phenotypic marker, sialophorin, associated with T cell vaccine immunity to fungal infection. Our findings show an essential role of sialophorin for fungal immunity, as a target of adjuvanticity, and as a potential biomarker of vaccine immunity against many fungal infections.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Combination adjuvants enhance recombinant protein vaccine protection against fungal infection
M. Wuethrich, H. E. Dobson, … B. S. Klein·bioRxiv·Mar 11, 2021
- Combination adjuvants drive long lived plastic Th17 cells that convert to multi-functional Th1 cells and protect mice against fungal infection
Marcel Wüthrich, Uju Joy Okaa, … Bruce S. Klein·mBioPeer-reviewed·Jun 11, 2026
- Structural basis of Blastomyces Endoglucanase-2adjuvancy in anti-fungal and -viral immunity
L. Dos Santos Dias, H. E. Dobson, … M. Wuethrich·bioRxiv·Jun 24, 2020
- Improved humoral immunity and protection against influenza virus infection with a 3D porous biomaterial vaccine
H. Miwa, O. Q. Antao, … D. Di Carlo·bioRxiv·Dec 16, 2022
- Natural Killer Cell Granule Protein (NKG7) promotes the development of vaccine-induced anti-fungal Th1 cells
Marcel Wüthrich, Cleison Ledesma Taira, … Bruce S. Klein·bioRxiv·Apr 23, 2026
- MAIT cells activate dendritic cells to promote T follicular helper cell differentiation and humoral immunity
T. E. Pankhurst, K. H. Buick, … L. M. Connor·bioRxiv·Mar 31, 2022